Projects
Thanks to our incredible supporters, we fund innovative and ground-breaking medical research towards finding new treatments and cures for Bone Marrow Failure Syndromes and improving patient outcomes
Using whole genome sequence analysis to find answers for unsolved cases of inherited bone marrow failure syndrome.
2020-2022 (GIA): Using whole genome sequence analysis to find answers for unsolved cases of inherited bone marrow failure syndrome. Dr Piers Blombery, The University of Melbourne.
Read moreThe RESELECT Trial – REscuing bone marrow function in patients with relapsed aplaStic anaEmia and/or bone marrow failure post aLlogeneic stEm Cell Transplantation.
2020-2023 (Program): The RESELECT Trial – REscuing bone marrow function in patients with relapsed aplaStic anaEmia and/or bone marrow failure post aLlogeneic stEm Cell Transplantation. PI – Professor David Ritchie.
Read moreThe Australian Bone Marrow Failure Biobank.
2020-2023 (Grant): The Australian Bone Marrow Failure Biobank. Professor Melissa Southey, Biobanking Victoria, Monash University.
Read moreDetermining genetic and epigenetic drivers of gene expression changes in blood cells.
2020-2023 (Fellowship): The Alex Gadomski PhD Scholarship in Medical Research, co-funded with the University of Tasmania. Determining genetic and epigenetic drivers of gene expression changes in blood cells. Ariel Simpson, Menzies Institute for ...
Read moreMicroenvironmental determinants of Aplastic Anaemia progression to MDS / AML.
2020-2021 (Grant-in-Aid): Microenvironmental determinants of Aplastic Anaemia progression to MDS / AML. Dr Rachel Koldej, ACRF Translational Research Laboratory, Melbourne Health. The Australian Cancer Research Foundation (ACRF) Translational ...
Read moreEstablishing an in vivo humanised mouse model for telomere related bone marrow failure syndromes.
2020-2021 (Grant-in-Aid): Establishing an in vivo humanised mouse model for telomere related bone marrow failure syndromes. Professor Tracy Bryan, Children’s Medical Research Institute. For the last 25 years, Professor Tracy Bryan has been ...
Read moreModelling consequences of cell abundance, heterogeneity and origin for autologous cell therapy in genetic bone marrow failure syndromes.
2020-2022 (Fellowship): Modelling consequences of cell abundance, heterogeneity and origin for autologous cell therapy in genetic bone marrow failure syndromes. Dr Parvathy Venugopal, Centre for Cancer Biology / University of South Australia. Dr ...
Read moreEvaluating Multidisciplinary Bone Marrow Failure Syndrome Care – a prospective observational clinical trial offering comprehensive diagnostic genomic evaluation, multidisciplinary case review and multidisciplinary clinical care
2019-2021 (Grant): Evaluating Multidisciplinary Bone Marrow Failure Syndrome Care – a prospective observational clinical trial offering comprehensive diagnostic genomic evaluation, multidisciplinary case review and multidisciplinary ...
Read moreExtension to The Australian Aplastic Anaemia and other Bone Marrow Failure Syndromes Registry
2019-2020 (Grant): Extension to The Australian Aplastic Anaemia and other Bone Marrow Failure Syndromes Registry (see above). Professor Erica Wood, Monash University Department of Epidemiology and Preventative Medicine. For further information, ...
Read moreFunctional interrogation of Loci associated with the Regulation of Haematopoiesis
2019-2021 (Fellowship): The Alex Gadomski Fellowship. Functional interrogation of Loci associated with the Regulation of Haematopoiesis. Dr Kirsten Fairfax, Menzies Institute for Medical Research and University of Tasmania. Dr Kirsten Fairfax is ...
Read moreNovel blood biomarkers for predicting bone marrow failure in Myeloproliferative neoplasms.
2018-2020 (co-funded Snowdome/Gunn Family/Maddie Riewoldt’s Vision) The Gunn Family National Fellowship for Career Development in Research – Women in Haematology. Novel blood biomarkers for predicting bone marrow failure in ...
Read moreNovel immunological assessment of Aplastic Anaemia and post transplant Graft Dysfunction for the purposes of targeted therapeutic intervention.
2018-2020 (Co-funded VCA/MRV International Travelling Fellowship): Novel immunological assessment of Aplastic Anaemia and post transplant Graft Dysfunction for the purposes of targeted therapeutic intervention. Dr Ashvind Prabahran, The Royal ...
Read more